Results 241 to 250 of about 6,836,951 (295)

Humanitarian Intervention

, 2010
openaire   +4 more sources

Network Localization of Fatigue in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Fatigue is among the most common symptoms and one of the main factors determining the quality of life in multiple sclerosis (MS). However, the neurobiological mechanisms underlying fatigue are not fully understood. Here we studied lesion locations and their connections in individuals with MS, aiming to identify brain networks ...
Olli Likitalo, Jaakko Kungshamn, Albert Bellmunt‐Gil, Silvia Tommasin, Abhineet Ojha, Matias Viitala, Juho Aaltonen, Jyrki Lötjönen, Juha Koikkalainen, Pauli Ylikotila, Patrizia Pantano, Merja Soilu‐Hänninen, Juho Joutsa   +12 more
wiley   +1 more source

Effects of rhythmic dumbbell upper limb rehabilitation training based on the multi-process action control framework on vascular access function and quality of life in hemodialysis patients. [PDF]

Front Surg
Hu J, Cao M, Jia R, Pan K, Jiang X.
europepmc   +1 more source

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock‐Guttman, Alexander Burnham, Niels Bergsland, Michael G. Dwyer, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +10 more
wiley   +1 more source

The effectiveness of a multidisciplinary collaborative intervention model on improving anxiety and depression in left-behind children and the study of its social support mechanisms. [PDF]

Front Public Health
Zhang Z.
europepmc   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Study on the effect of community intervention on patients with hypertension in high-normal blood pressure. [PDF]

Front Med (Lausanne)
Gao Q, Gao Z, Yang Q, Wang L, Xu L.
europepmc   +1 more source

Sleep psychoeducation strategies for patients with chronic migraine and sleep quality complaints. [PDF]

Arq Neuropsiquiatr
Andreis DG, Rodrigues MLF, Zanatta A, Marchioro IJM, Kowacs PA.   +4 more
europepmc   +1 more source